Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: antagonism by noggin
about
Systemically administered bone morphogenetic protein-6 restores bone in aged ovariectomized rats by increasing bone formation and suppressing bone resorptionOsteocyte control of bone formation via sclerostin, a novel BMP antagonistLevels of expression for BMP-7 and several BMP antagonists may play an integral role in a fracture nonunion: a pilot studyInterplay between bone morphogenetic proteins and cognate binding proteins in bone and cartilage development: noggin, chordin and DAN.TGF-β and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and diseaseBrown adipose tissue and boneScaffold-free microtissues: differences from monolayer cultures and their potential in bone tissue engineeringBone morphogenetic protein type IA receptor signaling regulates postnatal osteoblast function and bone remodelingCthrc1 is a positive regulator of osteoblastic bone formationTranscriptional responses of cultured rat sympathetic neurons during BMP-7-induced dendritic growthIn Vivo Evaluation of Adipose-Derived Stromal Cells Delivered with a Nanofiber Scaffold for Tendon-to-Bone Repair.Regional and cellular localisation of BMPs and their inhibitors' expression in human fractures.Bone morphogenic protein 2 directly enhances differentiation of murine osteoclast precursors.Fibrodysplasia ossificans progressiva-related activated activin-like kinase signaling enhances osteoclast formation during heterotopic ossification in muscle tissues.Genetic predisposition to fracture non-union: a case control study of a preliminary single nucleotide polymorphisms analysis of the BMP pathwayFunctional differentiation of uterine stromal cells involves cross-regulation between bone morphogenetic protein 2 and Kruppel-like factor (KLF) family members KLF9 and KLF13Bone morphogenetic protein regulation of early osteoblast genes in human marrow stromal cells is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase signaling.Disruption of the Fgf2 gene activates the adipogenic and suppresses the osteogenic program in mesenchymal marrow stromal stem cells.Mesenchymal stem cells with rhBMP-2 inhibits the growth of canine osteosarcoma cellsPediatric craniofacial surgery: a review for the multidisciplinary team.Regulation of BMP-induced transcription in cultured human bone marrow stromal cells.Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways.Consequences of daily administered parathyroid hormone on myeloma growth, bone disease, and molecular profiling of whole myelomatous bone.Preconditioning Human Mesenchymal Stem Cells with a Low Concentration of BMP2 Stimulates Proliferation and Osteogenic Differentiation In Vitro.Different effects of BMP-2 on marrow stromal cells from human and rat bone.The host microenvironment influences prostate cancer invasion, systemic spread, bone colonization, and osteoblastic metastasis.Bicuspid aortic valve disease: the role of oxidative stress in Lrp5 bone formation.Enhanced osteogenesis of adipose derived stem cells with Noggin suppression and delivery of BMP-2.Inhibition of bone morphogenetic protein signal transduction prevents the medial vascular calcification associated with matrix Gla protein deficiency.Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroidsEstrogens attenuate oxidative stress and the differentiation and apoptosis of osteoblasts by DNA-binding-independent actions of the ERalphaLack of noggin expression by cancer cells is a determinant of the osteoblast response in bone metastases.BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells.Synergistic induction of early stage of bone formation by combination of recombinant human bone morphogenetic protein-2 and epidermal growth factor.Conditional inactivation of noggin in the postnatal skeleton causes osteopeniaImpaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing mice.Repetitive recombinant human bone morphogenetic protein 2 injections improve the callus microarchitecture and mechanical stiffness in a sheep model of distraction osteogenesis.Control and augmentation of long-term plasmid transgene expression in vivo in murine muscle tissue and ex vivo in patient mesenchymal tissueParathyroid hormone induces differentiation of mesenchymal stromal/stem cells by enhancing bone morphogenetic protein signaling.Effect of bone morphogenetic protein 2 on tendon-to-bone healing in a canine flexor tendon model
P2860
Q24294642-18DE9C25-2A0C-457B-AA62-649E8453B6ACQ24300347-EBA9949B-54A3-42F1-A039-64859677F78EQ24645095-FCB15F08-E15E-4D1B-B78A-7BE0609F8CF3Q24805190-794CFE51-D565-4E73-89C5-3C87A26D4A59Q26738766-7B53AB42-637C-481E-B66E-7DD7591A558BQ26751885-A0D63EC7-4BB7-4F37-BF76-E04ABC944BF9Q26998529-C185779C-E0B1-478C-B345-ACC2EC4BC5A6Q28257036-9317EC8F-B0C0-4A2C-AE5B-DA1191937BECQ28511903-28E702CD-AA91-4F3F-8083-23A65695F1F9Q28742676-4D7529F5-AACA-4D7E-A44B-43A4B2B80ACEQ30679638-E2522467-E7AA-484B-84AF-11C98D611850Q33386046-67FEDC1F-C504-4098-9BDB-EC70E8CEC67EQ33719492-BB0C9FEF-E118-4044-970D-BCAADE34C218Q33761255-CA67498B-85DA-44FC-B795-C46ECABCF0C0Q33817497-EFA02B3A-D1F2-462C-AEDE-233E6189CB63Q33993770-D837FF30-A2C4-4BA1-BABA-803E1B06F67FQ34049570-0F175723-386D-4605-9BD2-0EF4A94C2A1FQ34163238-DF327904-3D4D-4D97-ADE5-0C4BE802DE2DQ34167024-510591CD-E2D3-4699-9079-B4335C7EACE6Q34198886-38119FF1-598E-42EE-9D7A-68D4F702AA83Q34313048-F4F83C19-B217-4347-BB08-C5F275C6E2E6Q34371949-B36B2329-5082-4C6F-B21E-C487FF5A76DFQ34418934-CF537C00-FE78-40F6-9203-AED620505512Q34579496-0F17953E-4626-44D3-A3C3-C455F503825FQ34620442-E0A2EE5A-63F7-4980-B164-6750D6D1D618Q34699785-3ECFCB60-D78B-4E65-BA10-5027D4EEF5FBQ34900192-1F34BB75-6CFB-4BCA-A814-0EF19E691CD9Q34973873-94111F0F-70C0-47B5-A95C-692A7319C2BAQ34989385-848874C3-DCE9-4C50-AEFC-C271E497CDF1Q35058081-2E0F1268-CA48-43CC-AEC6-4C0B942E2F05Q35156067-144652F1-683C-4AA3-9C74-F820FCA56B7CQ35570431-8363A37C-845C-4895-928D-0143C981E5C2Q35643930-76C16D5D-5B8C-4AD3-99FE-6B671D5DE76EQ35835009-9D965E4F-A933-40E5-8FD7-A9AA8897923CQ35872773-E0C864BF-1C87-47B6-AAD2-1A87183196A7Q35919695-AEFD13AF-7647-4829-9BEE-BC81EC089ECAQ35948052-C4700F06-B2E3-4F7A-BC51-3EF9AD68FDCEQ36091207-331DEE95-A8D7-4F0D-A41E-8067EC26B954Q36177028-77AD42CD-2FC7-4F64-882F-8CB3C755F1C7Q36189347-FB4338F7-ED16-4ED2-9C7A-EAB61A452577
P2860
Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: antagonism by noggin
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Essential requirement of BMPs- ...... ult mice: antagonism by noggin
@ast
Essential requirement of BMPs- ...... ult mice: antagonism by noggin
@en
Essential requirement of BMPs- ...... ult mice: antagonism by noggin
@en-gb
Essential requirement of BMPs- ...... ult mice: antagonism by noggin
@nl
type
label
Essential requirement of BMPs- ...... ult mice: antagonism by noggin
@ast
Essential requirement of BMPs- ...... ult mice: antagonism by noggin
@en
Essential requirement of BMPs- ...... ult mice: antagonism by noggin
@en-gb
Essential requirement of BMPs- ...... ult mice: antagonism by noggin
@nl
prefLabel
Essential requirement of BMPs- ...... ult mice: antagonism by noggin
@ast
Essential requirement of BMPs- ...... ult mice: antagonism by noggin
@en
Essential requirement of BMPs- ...... ult mice: antagonism by noggin
@en-gb
Essential requirement of BMPs- ...... ult mice: antagonism by noggin
@nl
P2093
P921
P3181
P1476
Essential requirement of BMPs- ...... ult mice: antagonism by noggin
@en
P2093
Lecka-Czernik B
Manolagas SC
O'Brien CA
Yamamoto M
P304
P3181
P356
10.1359/JBMR.2000.15.4.663
P407
P577
2000-04-01T00:00:00Z